Table 3: Multiancestral asthma PRS performance in three independent cohorts.
Pediatric Cohorts | AUC (Full model)I | pseudo R2 | OR per one SDII |
---|---|---|---|
European ancestry | |||
Training | 0.67 (0.64–0.70) | 0.05 | 1.27 (1.12–1.44) |
Validation 1 | 0.60 (0.57–0.63) | 0.02 | 1.20 (1.08–1.34) |
Validation 2 | 0.66 (0.65–0.67) | 0.04 | 1.57 (1.55–1.60) |
African ancestry | |||
Training | 0.57 (0.54–0.60) | 0.01 | 1.13 (1.01–1.26)III |
Validation 1 | 0.61 (0.58–0.63) | 0.02 | 1.27 (1.14–1.42) |
Validation 2 | 0.66 (0.63–0.69) | 0.03 | 1.43 (1.24–1.65) |
Admixed American ancestry | |||
Training | 0.68 (0.64–0.72) | 0.07 | 1.61 (1.28–2.02) |
Validation 1 | 0.64 (0.61–0.68) | 0.03 | 1.25 (1.06–1.47) |
Validation 2 | 0.70 (0.67–0.74) | 0.07 | 1.63 (1.36–1.95) |
Eastern Asian ancestry | |||
Validation 2 | 0.73 (0.66–0.80) | 0.08 | 1.32 (0.99–1.77)III |
Southern Asian ancestry | |||
Validation 2 | 0.65 (0.62–0.68) | 0.03 | 1.32 (1.18–1.48) |
AUC Full model includes age, sex and 10 principal components
The odds ratio per one standard deviation of PRS distribution (logistic regression P<0.0001)
For the African Ancestry eMERGE datasets 1- Pediatric and Eastern Asian UK Biobank-Pediatric cohorts, P=0.03 and P=0.07 respectively.